Akero Therapeutics, Inc.

NasdaqGS:AKRO 주식 보고서

시가총액: US$2.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Akero Therapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGS:AKRO 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
10 Sep 24SellUS$45,501Andrew ChengIndividual1,738US$26.18
10 Sep 24SellUS$14,059Timothy RolphIndividual537US$26.18
10 Sep 24SellUS$16,729William WhiteIndividual639US$26.18
10 Sep 24SellUS$16,677Catriona YaleIndividual637US$26.18
10 Sep 24SellUS$14,870Jonathan YoungIndividual568US$26.18
11 Jun 24SellUS$178,728Andrew ChengIndividual7,894US$22.64
11 Jun 24SellUS$53,886Timothy RolphIndividual2,380US$22.64
11 Jun 24SellUS$12,883Patrick LamyIndividual569US$22.64
11 Jun 24SellUS$64,094William WhiteIndividual2,831US$22.64
11 Jun 24SellUS$63,961Catriona YaleIndividual2,825US$22.64
11 Jun 24SellUS$56,965Jonathan YoungIndividual2,516US$22.64
13 Mar 24SellUS$18,443Jonathan YoungIndividual651US$28.33
13 Mar 24SellUS$20,483Catriona YaleIndividual723US$28.33
13 Mar 24SellUS$20,511William WhiteIndividual724US$28.33
13 Mar 24SellUS$55,782Andrew ChengIndividual1,969US$28.33
13 Mar 24SellUS$17,536Timothy RolphIndividual619US$28.33
14 Dec 23SellUS$11,273Jonathan YoungIndividual543US$20.76
14 Dec 23SellUS$10,671Timothy RolphIndividual514US$20.76
14 Dec 23SellUS$12,394Catriona YaleIndividual597US$20.76
14 Dec 23SellUS$33,797Andrew ChengIndividual1,628US$20.76
14 Dec 23SellUS$12,684William WhiteIndividual611US$20.76
08 Dec 23BuyUS$1,982,940Logos Global Management, L.P.Company100,000US$19.85
01 Dec 23BuyUS$1,694,565Logos Global Management, L.P.Company100,000US$16.99
17 Nov 23SellUS$440,259Jonathan YoungIndividual30,000US$14.68

내부자 거래량

내부자 구매: AKRO insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

AKRO 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
개인 내부자1,221,4471.57%
공공 기업2,525,2523.24%
VC/PE 기업5,233,9896.72%
헤지 펀드5,431,9856.98%
교육기관63,436,49281.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 25% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 94.15%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
10.1%
Wellington Management Group LLP
7,029,624US$206.2m37.4%0.03%
9.9%
Janus Henderson Group plc
6,876,253US$201.7m12.3%0.08%
8.52%
T. Rowe Price Group, Inc.
5,913,594US$173.5m14.6%0.01%
8.05%
BlackRock, Inc.
5,586,637US$163.9m14.2%데이터 없음
7.82%
RTW Investments, LP
5,431,985US$159.4m0%2.27%
7.54%
General Atlantic Service Company, L.P.
5,233,989US$153.6m0%2.44%
5.34%
The Vanguard Group, Inc.
3,705,090US$108.7m0.96%데이터 없음
4.02%
Alkeon Capital Management, LLC
2,793,653US$82.0m0%0.52%
3.87%
State Street Global Advisors, Inc.
2,689,426US$78.9m-29.2%데이터 없음
3.64%
Pfizer Inc.
2,525,252US$74.1m0%데이터 없음
2.75%
AllianceBernstein L.P.
1,907,857US$56.0m17.7%0.02%
2.41%
Tavistock Life Sciences
1,676,733US$49.2m0%2.35%
2.33%
Geode Capital Management, LLC
1,619,039US$47.5m14.1%데이터 없음
2.33%
Redmile Group, LLC
1,614,473US$47.4m-13.1%2.08%
2.16%
Perceptive Advisors LLC
1,499,897US$44.0m8.1%0.93%
2.07%
Yiheng Capital Management, L.P.
1,434,179US$42.1m0%4.6%
1.58%
Baker Bros. Advisors LP
1,097,082US$32.2m-59.6%0.24%
1.56%
Braidwell LP
1,084,400US$31.8m0%1.42%
1.55%
Rock Springs Capital Management LP
1,074,261US$31.5m-17.4%0.87%
1.35%
Emerald Advisers, LLC
940,153US$27.6m-2.45%0.58%
1.31%
Morgan Stanley, Investment Banking and Brokerage Investments
906,125US$26.6m162%데이터 없음
1.15%
Logos Global Management, L.P.
800,000US$23.5m0%2.45%
1.04%
Long Focus Capital Management LLC
719,604US$21.1m119%1.93%
0.9%
Silverarc Capital Management, LLC
625,087US$18.3m56.3%4.26%
0.85%
Northern Trust Global Investments
587,866US$17.2m-1.64%데이터 없음